This antibody is purified through a protein A column, followed by peptide affinity purification.
Immunogen
This ELOVL2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1-27 amino acids from the N-terminal region of human ELOVL2.
Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
4 °C,-20 °C
Informationen zur Lagerung
Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.
Haltbarkeit
6 months
Meller, VAN Ellen, Gevensleben, Bicker, Hankeln, Gorr, Sailer, Dröge, Schröck, Bootz, Schröck, Perner, Dietrich, Kristiansen: "Ectopic Myoglobin Expression Is Associated with a Favourable Outcome in Head and Neck Squamous Cell Carcinoma Patients." in: Anticancer research, Vol. 36, Issue 12, pp. 6235-6241, (2017) (PubMed).
AI317360 antikoerper, Ssc2 antikoerper, SSC2 antikoerper, elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 2 antikoerper, ELOVL fatty acid elongase 2 antikoerper, Elovl2 antikoerper, ELOVL2 antikoerper
Hintergrund
ELOVL2 could be implicated in tissue-specific synthesis of very long chain fatty acids and sphingolipids. This protein may catalyze one or both of the reduction reaction in fatty acid elongation, i.e., conversion of beta-ketoacyl CoA to beta-hydroxyacyl CoA or reduction of trans-2-enoyl CoA to the saturated acyl CoA derivative (By similarity).